NCT02933307
- Conditions
- Adenocarcinoma, Arthritis, Carcinoma, +31 more
- Locations
-
Not specified
Clinical trial condition
Colorectal Neoplasms
Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.
428 public trials
68 recruiting studies
Colorectal Neoplasms trial results
Completed
Levocetirizine + Capecitabine + Bevacizumab for Patients With Refractory Colorectal Cancer
NCT01722162
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT02141945
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Cancer, +10 more
- Locations
-
- DC Endoscopy Center Washington D.C., District of Columbia, United States
- Chevy Chase Endoscopy Center Chevy Chase, Maryland, United States
Completed
First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib
NCT01289821
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- Chicago, Illinois, United States
- Concord, New South Wales, Australia
- Woodville South, South Australia, Australia
- Bruxelles - Brussel, Belgium
NCT00056446
- Conditions
- Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +10 more
- Locations
-
- Comprehensive Cancer Institute Huntsville, Alabama, United States
- Alaska Oncology and Hematology Anchorage, Alaska, United States
- Arizona Clinical Research Center Tucson, Arizona, United States
- Northeast Arkansas Clinic Jonesboro, Arkansas, United States
NCT01819766
- Conditions
- Bile Duct Diseases, Biliary Tract Diseases, Cholangitis, +17 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- UC San Diego Medical Center La Jolla, California, United States
- University of Miami Miami, Florida, United States
- Rush University Medical Center Chicago, Illinois, United States
Completed
Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) Genotype
NCT01450319
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- Research Site A Coruña, Spain
- Research Site Asturias, Spain
- Research Site Barcelona, Spain
- Research Site Córdoba, Spain
Completed
MS Versus NICE for Colorectal Lesions
NCT02963207
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Colorectal Polyp, +9 more
- Locations
-
Not specified
NCT01903395
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- Kliniken Landkreis Sigmaringen GmbH Sigmaringen, Baden-Wurttemberg, Germany
- Klinikum Ludwigsburg Ludwigsburg, Baden-Würtemberg, Germany
- Diakoniekrankenhaus Mannheim Mannheim, Baden-Würtemberg, Germany
- Klinikum Stuttgart Krankenhaus Bad Cannstatt Stuttgart, Baden-Würtemberg, Germany
Completed
A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)
NCT00190515
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- Aichi Cancer Center Hospital Nagoya,Chikusa-ku,Kanokoden,1-1, Aichi-ken, Japan
- Fujita Health University Toyoake,Kutsukake-cho,Dengakugakubo,1-98, Aichi-ken, Japan
- Chiba Cancer Center Hospital Chiba,Chuo-ku,Nitona-cho,666-2, Chiba, Japan
- National Cancer Center Hospital East Kashiwa,Kashiwanoha,6-5-1, Chiba, Japan